Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,260.00    -130.00 (-2.41%)
Bid:
5,255.00
Ask:
5,270.00
Spread: 15.00 (0.285%)
Market Cap: £3.83b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

24 Oct 2024 07:00

RNS Number : 3723J
Renishaw PLC
24 October 2024
 

Renishaw plc

Trading update

24 October 2024

 

 

Solid revenue and profit growth in mixed trading conditions

Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update for the three months ended 30 September 2024. It contains unaudited information that covers the first quarter of the financial year.

 

 

Trading activity

 

 

3 months to 30 September 2024

3 months to 30 September 2023

Change

 

 

 

 

Manufacturing technologies

£167.5m

£156.8m

+7%

Analytical instruments and medical devices

£6.4m

£7.7m

-16%

Total revenue

£173.9m

£164.5m

+6%

Total revenue at constant exchange rates1

£171.3m

£165.0m

+4%

 

 

 

Adjusted profit before tax2

£34.0m

£28.0m

+22%

Statutory profit before tax

£34.0m

£28.0m

+22%

 

 

Revenue was £173.9m, representing a 6% increase compared to the corresponding period last year at actual exchange rates, and a 4% increase at constant currency1. The Americas and EMEA regions saw increased demand compared to Q1 FY2024, whilst APAC was lower compared to a strong period last year, which was boosted by orders from the consumer electronics sector. 

 

In our Manufacturing technologies business, revenue in the period was 7% higher than the prior year at £167.5m. Sales of position encoders to the semiconductor manufacturing sector saw strong growth compared to a subdued prior year comparator. Our Additive Manufacturing products also grew strongly, reflecting the good order book carried into FY2025. Meanwhile, demand for Industrial Metrology products was lower than last year, primarily due to the strong prior period sales to consumer electronics manufacturers in APAC.

 

Revenue for our Analytical instruments and medical devices business was £6.4m, a decrease of 16% compared with £7.7m last year, primarily from phasing for our Spectroscopy products.

 

Adjusted and Statutory profit before tax2 for the first quarter of FY2025 both amounted to £34.0m (FY2024: £28.0m).

 

 

Financial position

 

The Group's balance sheet remains strong with net cash and cash equivalents and bank deposit balances of £276.1m on 30 September 2024 (30 June 2024: £217.8m).

 

 

Outlook

 

The first quarter of FY2025 has seen solid revenue and profit growth in mixed trading conditions, with subdued demand in some markets, offset by good growth elsewhere. Whilst Q1 sales of our encoder products to the semiconductor manufacturing sector have been stronger than last year, we remain cautious about demand from this market in the remainder of FY2025. 

 

We continue to pursue a range of growth opportunities and anticipate solid overall revenue growth this year in line with the Board's expectations. Alongside this we also remain focused on the careful management of costs and delivery of productivity improvements, which together will help drive progress towards our margin objectives.

The results for the half year ending 31 December 2024 will be released on 13 February 2025.

 

Will Lee

Allen Roberts

 

Chief Executive

Group Finance Director

 

 

24 October 2024

 

 

Renishaw plc

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

01106260

Telephone number

+44 (0) 1453 524524

Website

www.renishaw.com

 

 

 

Notes

 

1. Revenue at constant exchange rates is defined as revenue recalculated using the same rates that were applicable to the previous year and excluding forward contract gains and losses.

2. There are no adjustments made between statutory and adjusted profit before tax.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKEDALELFFA
Date   Source Headline
3rd Oct 20147:00 amRNSTrading Statement
10th Sep 201410:04 amRNSDirector/PDMR Shareholding
4th Sep 201411:56 amRNSDirectorate Change
22nd Aug 20148:22 amRNSAnnual Financial Report
12th Aug 20142:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSFinal Results
8th Jul 20147:28 amRNSNotice of Results
12th Jun 20147:27 amRNSHolding(s) in Company
20th May 20147:39 amRNSDirector/PDMR Shareholding
14th May 20147:00 amRNSInterim Management Statement
11th Mar 20147:00 amRNSStatement re Investor day
30th Jan 20147:00 amRNSHalf Yearly Report
13th Jan 20141:58 pmRNSNotice of Results
19th Dec 201310:34 amRNSHolding(s) in Company
27th Nov 20138:38 amRNSDirector/PDMR Shareholding
18th Nov 201311:31 amRNSForm 8.3 - Delcam PLC
7th Nov 20137:06 amRNSStatement re offer for shareholding in Delcam plc
17th Oct 20131:41 pmRNSResult of AGM
17th Oct 201310:55 amRNSInterim Management Statement
8th Oct 20133:25 pmRNSStatement re date of Interim management statement
19th Sep 20134:09 pmRNSDirector/PDMR Shareholding
23rd Aug 20139:57 amRNSAnnual Financial Report
21st Aug 20131:41 pmRNSDirectorate Change
24th Jul 20137:00 amRNSFinal Results
22nd Jul 20131:07 pmRNSNotice of Results
18th Jul 20137:36 amRNSHolding(s) in Company
3rd May 20137:00 amRNSInterim Management Statement
23rd Apr 20137:40 amRNSHolding(s) in Company
22nd Apr 20131:32 pmRNSStatement re Date of Interim managment statement
11th Apr 201312:15 pmRNSDirectorate Change
31st Jan 20131:27 pmRNSHolding(s) in Company
30th Jan 20137:07 amRNSStatement re webcast of interim results
30th Jan 20137:00 amRNSHalf Yearly Report
16th Jan 201310:34 amRNSHolding(s) in Company
21st Dec 201210:45 amRNSDirector/PDMR Shareholding
17th Dec 20123:45 pmRNSDirector/PDMR Shareholding
8th Nov 20127:42 amRNSDirector/PDMR Shareholding
31st Oct 20129:49 amRNSStatement re shareholders voting agreement
22nd Oct 201210:13 amRNSDirector/PDMR Shareholding
18th Oct 20122:11 pmRNSResult of AGM
18th Oct 201210:30 amRNSInterim Management Statement
10th Oct 20127:22 amRNSDirectorate Change
20th Sep 201212:13 pmRNSDirector Declaration
13th Sep 20123:27 pmRNSDirector/PDMR Shareholding
24th Aug 20128:47 amRNSAnnual Report and Accounts 2012 and Notice of AGM
2nd Aug 20127:53 amRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSFinal Results
23rd Jul 20121:19 pmRNSNotice of Results
15th May 20127:00 amRNSInterim Management Statement
10th May 20121:26 pmRNSStatement re date of Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.